Home007570 • KRX
add
Ilyang Pharmaceutical Co Ltd
Previous close
₩13,050.00
Year range
₩9,540.00 - ₩15,490.00
Market cap
254.79B KRW
P/E ratio
14.95
Dividend yield
1.15%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 68.83B | -0.38% |
Operating expense | 27.66B | 9.71% |
Net income | 8.44B | 141.68% |
Net profit margin | 12.26 | 142.77% |
Earnings per share | — | — |
EBITDA | 1.93B | -71.68% |
Effective tax rate | 26.58% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.47B | -38.71% |
Total assets | 452.76B | -15.15% |
Total liabilities | 204.95B | -21.85% |
Total equity | 247.81B | — |
Shares outstanding | 18.42M | — |
Price to book | 0.99 | — |
Return on assets | -0.09% | — |
Return on capital | -0.11% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 8.44B | 141.68% |
Cash from operations | 6.80B | 197.54% |
Cash from investing | 284.16M | 102.01% |
Cash from financing | -3.22B | -115.04% |
Net change in cash | 4.12B | 43,277.18% |
Free cash flow | -7.60B | 67.58% |
About
Founded
Jul 1, 1946
Website
Employees
670
